Monday, November 30, 2020

CDC Panel Plans Meeting to Discuss Distribution of COVID-19 Vaccine; Medical Experts Urge CDC to Warn People of COVID-19 Vaccine Side Effects, and other C-Virus Updates

CDC panel plans meeting to discuss distribution of COVID-19 vaccine:
A panel of advisers to the Centers for Disease Control and Prevention are expected to meet Tuesday to discuss who should first receive the COVID-19 vaccine once it’s been approved.
The CDC’s Advisory Committee on Immunization Practices wants to vote on who should receive the first batches of the vaccine prior to the Food and Drug Administration deciding on an emergency-use authorization, the committee’s chair, Dr. Jose Romero told CNN.
Medical experts have suggested health workers should receive the vaccine first, followed by essential workers, and then people with high-risk medical conditions and those 65 and older. --->READ MORE HERE
Medical experts urge CDC to warn people of COVID-19 vaccine side effects:
Medical experts this week urged advisers to the Centers for Disease Control and Prevention that the agency should warn Americans that the side effects from a COVID-19 vaccine won’t be “a walk in the park.”
Dr. Sandra Fryhofer of the American Medical Association said patients will need to be prepared to endure the potentially grueling side effects that come with Pfizer’s and Moderna’s vaccines — or they won’t come back for the necessary second dose, CNBC reported.
“We really need to make patients aware that this is not going to be a walk in the park,” Fryhofer said at an online meeting Monday with the Advisory Committee on Immunization Practices, a group of medical experts that advises the CDC. --->READ MORE HERE
Follow links below to related stories and resources:

Trump says coronavirus vaccine deliveries will start next week

UK plans ‘Christmas bubbles’ for families to celebrate amid COVID-19

USA TODAY: Coronavirus Updates

WSJ: Coronavirus Live Updates

YAHOO NEWS: Coronavirus Live Updates

NEW YORK POST: Coronavirus The Latest

If you like what you see, please "Like" us on Facebook either here or here. Please follow us on Twitter here.

No comments: